Igor Hall

Doctor of Medicine,  Mayo Clinic - Rochester 

Location: United States

Consulting Services

Career Advice and Mentoring Research Consulting

Areas Of Interest

Stamp, Postage Hepatitides, Infectious Herpestes Cofilin, Muscle Antigens, CD275 Lactones, Acyl-Homoserine Micrometastasis, Neoplasm L-Type Voltage-Dependent Calcium Channels Hepa Merz Sil Migraine c-erbA Proto-Oncogenes Oral Glucose Tolerance Test Angiogenesis, Corneal Deaminase, Porphobilinogen Near East Equine Encephalomyelitis Virus T Cell Receptors alpha Chain Enzymes, Cytochrome P-450 Leprechaunisms Nucleotide Sequence Echocardiography, Doppler, Pulsed Outlet Impingement Proto-Oncogene Protein, HER-2 Dinucleotide, Nicotinamide-Adenine Methylguanidine Experimental Autoimmune Myositis Expenditures, Health Collagen Type II Spiraeas SHC (Src Homology 2 Domain-Containing) Transforming Protein 1 Protamine Kinase Plants, Iris Drugs, Anticonvulsant

Professional Narrative

Dr. Igor Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 1987
Executive Director, Harvard Med 2016

Education

Master of Science in physician assistant, Yale School of Medicine 1991
Director Medicine, Yale School of Medicine 1989

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :